Home › Hodgkin Lymphoma
Pag-aaral pangklinika para sa Hodgkin Lymphoma na nagre-recruit sa U.S.
62 pag-aaral para sa Hodgkin Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX14 pag-aaral
- New York City, NY11 pag-aaral
- Baldwin Park, CA9 pag-aaral
- Boston, MA9 pag-aaral
- Miami, FL8 pag-aaral
- Memphis, TN7 pag-aaral
- Philadelphia, PA6 pag-aaral
- Greenburgh, NY5 pag-aaral
- Mountain View, CA5 pag-aaral
- Atlanta, GA5 pag-aaral
- Durham, NC4 pag-aaral
- Aurora, CO4 pag-aaral
- Madison, WI4 pag-aaral
- Edison, NJ4 pag-aaral
- Queens, NY4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Washington, DC4 pag-aaral
- Denver, CO3 pag-aaral
- New Rochelle, NY3 pag-aaral
- East Norwalk, CT3 pag-aaral
- Staten Island, NY3 pag-aaral
- Sacramento, CA3 pag-aaral
- Baltimore, MD3 pag-aaral
- Orange, CA3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Seattle, WA3 pag-aaral
- Columbus, OH3 pag-aaral
- Chicago, IL3 pag-aaral
- Los Angeles, CA3 pag-aaral
- San Francisco, CA3 pag-aaral
- Indianapolis, IN3 pag-aaral
- Minneapolis, MN3 pag-aaral
Ayos sa estado
- California15 pag-aaral
- Colorado5 pag-aaral
- Florida12 pag-aaral
- Georgia7 pag-aaral
- Illinois4 pag-aaral
- Indiana4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts9 pag-aaral
- Minnesota4 pag-aaral
- New Jersey5 pag-aaral
- New York15 pag-aaral
- North Carolina6 pag-aaral
- Ohio4 pag-aaral
- Pennsylvania7 pag-aaral
- Tennessee8 pag-aaral
- Texas15 pag-aaral
- Washington4 pag-aaral
- Wisconsin8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Nagre-recruitPhase 1
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06176690CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Nagre-recruitPhase 1
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT02917083Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07285044Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT02682667Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03418038Tissue Collection for Studies of Lymph Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01676805Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03618550Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06398457A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Nagre-recruitPhase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT05272384Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07444632Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06421987Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
Nagre-recruitPhase 2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07551583Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07514819ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07021989CD45BE-HSPC + CART-45 Cells
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07451054Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Nagre-recruitPhase 1/2
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05092451ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06090864Personalized NK Cell Therapy in CBT
Nagre-recruitPhase 2
Edad 15 hanggang 80 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07020533A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06150664Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT06580002Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.